Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Asia Deal Watch: Astellas, GO Team Up On Targeted Cancer Therapy

02 Jun 2022

• By Joseph Haas, Jung Won Shin, Dexter Jie Yan, and Lisa Takagi

Asia Deal Watch — • Source: Alamy

Related Content

IFC And Nippon Chemiphar Ally In Asia, Middle East And Africa

17 May 2022

Henlius Brings In Abbott As Another Partner In Brazil

26 May 2022

Deal Watch: Astellas/Cytokinetics Extend Partnership, Make Progress On SMA Candidate

05 Oct 2018

The end is nigh for GSK's darapladib

13 May 2014

Antifungal Specialist F2G Gets Near $61m Financing

12 Aug 2020

Torrent Acquires Chronic Brands From Dr. Reddy’s, Folds Up US Liquids Business

27 May 2022

High Hopes For Heidelberg Pharma With Huadong Onboard

25 May 2022

Medipost Accelerates Global Push For Lead Stem Cell Therapy

16 Mar 2021

Cala Health Hopes To Jolt Essential Tremor Market With Wrist-Worn Non-Invasive Stimulation

19 Nov 2021

Related Companies

Astellas Pharma, Inc.

GO Therapeutics

Xyphos Biosciences, Inc.

Roche Holding AG

SciNeuro Pharmaceuticals

GSK plc

Medipost Co., Ltd.

ImaginAb, Inc.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Chia Tai Tianqing Pharmaceutical Group Co., Ltd

Sino Biopharmaceutical Limited

Symphogen A/S

Cala Health, Inc.

SK Biopharmaceuticals Co., Ltd

Shionogi & Co. Ltd.

F2G Ltd

Additional Topics

Asia Pacific Business Strategies Deals M & A Commercial Deal Watch BioPharmaceutical

More from Deal Watch

More from Deals

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.